A Pneumococcal Protein Array as a Platform to Discover Serodiagnostic Antigens Against Infection

Alfonso Olaya-Abril1, Irene Jiménez-Munguía1, Lidia Gómez-Gascón2

  • 1From the ‡Departamento de Bioquímica y Biología Molecular, Universidad de Córdoba; Campus de Excelencia Internacional CeiA3; and Red Española de Investigación en Patología Infecciosa (REIPI), Instituto de Salud Carlos III, Madrid, Spain;

Insights

Diagnosing childhood pneumococcal pneumonia is difficult. A new protein array identified three key antigens (PblB, PulA, PrtA) for accurate serodiagnosis in children under four.

Area of Science:

  • Microbiology
  • Immunology
  • Proteomics

Background:

  • Pneumonia, a severe disease caused by Streptococcus pneumoniae, presents diagnostic challenges in children due to test limitations and distinguishing infection from colonization.
  • Current diagnostic methods for pediatric pneumococcal pneumonia are often inadequate, necessitating the development of improved serological assays.
  • Serological approaches are gaining traction for diagnosing pediatric pneumococcal pneumonia, offering a promising alternative to existing methods.

Purpose of the Study:

  • To develop a novel protein array for simultaneous screening of antibody responses against multiple Streptococcus pneumoniae antigens.
  • To identify specific protein antigens that can reliably diagnose pneumococcal pneumonia in children.
  • To create a basis for developing user-friendly and affordable diagnostic tests.

Main Methods:

  • Proteomics approach involving protease "shaving" of bacterial cell surfaces and LC/MS/MS analysis of 24 pediatric clinical isolates.
  • Recombinant production and printing of 95 identified proteins onto an array.
  • Probing the protein array with sera from children diagnosed with pneumococcal pneumonia.

Main Results:

  • A protein array was successfully developed, enabling simultaneous antibody response screening.
  • A discriminant response was identified for three specific antigens (PblB, PulA, and PrtA) in children under 4 years old with pneumococcal pneumonia.
  • ELISA and immunostrip assays validated these findings, demonstrating potential for easy-to-use diagnostic tools.

Conclusions:

  • The developed protein array serves as a valuable tool for broad serodiagnostic applications in pneumococcal pneumonia.
  • The identified antigens (PblB, PulA, PrtA) show promise for accurate and specific diagnosis of pediatric pneumococcal pneumonia.
  • This research paves the way for affordable and accessible serodiagnostic tests for children.